Viewing Study NCT06378866


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2026-02-01 @ 1:49 PM
Study NCT ID: NCT06378866
Status: RECRUITING
Last Update Posted: 2025-10-16
First Post: 2024-04-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Castration-Sensitive Prostate Carcinoma View
None Stage IVB Prostate Cancer AJCC v8 View
None Recurrent Prostate Cancer View
None Castration-resistant Prostate Cancer View
Keywords: